BPC-157
Faster capillary recovery, less fibrosis.
SC injection (near injury site or systemic); oral; IV infusion — 250–500 mcg SC injection daily (evening); 250 mcg IV in Core IV formulas; oral for gut protocols
What It Is
BPC-157 is a pentadecapeptide derived from gastric protein. It is a potent regenerative peptide that promotes angiogenesis, granulation tissue formation, and has anti-inflammatory effects.
Mechanism
BPC-157 promotes angiogenesis and endothelial protection, tempers cytokines (TNF-α), and accelerates capillary regrowth while reducing edema and fibrosis risk. It specifically helps rebuild microvasculature and protects endothelial cells, which translates to faster capillary regrowth in wounds and reduced swelling and bruising. It reduces pro-inflammatory cytokines (TNF-α, IL-6) and heals gut lining.
How Dr. Emer Uses It
Dr. Emer uses BPC-157 as a core component of the Wolverine Stack (with TB-500), given 250–500 mcg SC daily (typically each evening) around an injury or incision site. Pre-surgically, it is used alongside GLP-1 agonists as a "metabolic tune-up." Post-procedure, it is continued for 4–6 weeks to speed healing of wounds, laser-treated skin, and surgical incisions. Also used orally for gut inflammation and as a concurrent agent alongside GLP-1 therapy to protect the GI mucosa.
Key Benefits
- ✓Promotes angiogenesis and accelerated capillary regrowth in wounds
- ✓Reduces pro-inflammatory cytokines (TNF-α, IL-6) and systemic inflammation
- ✓Heals gut lining and reduces GLP-1-induced gut inflammation
- ✓Reduces edema, bruising, and fibrosis risk post-procedure
- ✓Reinforces dermal microvasculature to reduce swelling
- ✓Supports cartilage repair and joint healing as adjunct in joint recovery stacks
Pairs Well With
Used In Programs
Safety & Considerations
Excellent safety profile; mostly anecdotal reports of mild nausea. Not FDA-approved (research use); informed consent is obtained. No known significant risks besides theoretical angiogenesis concern in active tumor patients — avoid if active malignancy. Investigational drug status; document consent.
Begin Your RECODEX™ Protocol
All peptide therapies are prescribed under direct medical supervision.
Book a Consultation
